Compounds > fexinidazole
Page last updated: 2024-08-25

fexinidazole and miltefosine

fexinidazole has been researched along with miltefosine in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (85.71)24.3611
2020's1 (14.29)2.80

Authors

AuthorsStudies
Azas, N; Cantelli, C; Casanova, M; Castera-Ducros, C; Cohen, A; Crozet, MD; Hutter, S; Laget, M; Paloque, L; Rathelot, P; Remusat, V; Tanguy, F; Vanelle, P; Verhaeghe, P1
Azas, N; Castera-Ducros, C; Cohen, A; Hutter, S; Kieffer, C; Laget, M; Paloque, L; Rathelot, P; Rault, S; Valentin, A; Vanelle, P; Verhaeghe, P1
Ang, CW; Blaskovich, MAT; Cooper, MA; Jarrad, AM1
Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, E; Courtioux, B; Fairlamb, A; Hutter, S; Laget, M; Moreau, A; Mothes, E; Paloque, L; Pedron, J; Pratviel, G; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vendier, L; Verhaeghe, P; Wyllie, S1
Azas, N; Boudot, C; Bourgeade-Delmas, S; Castera-Ducros, C; Cohen, A; Courtioux, B; Crozet, MD; Fairlamb, A; Fersing, C; Hutter, S; Moreau, A; Pedron, J; Pratviel, G; Primas, N; Rathelot, P; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S1
Azas, N; Basmaciyan, L; Belle Mbou, V; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, É; Casanova, M; Castera-Ducros, C; Cohen, A; Courtioux, B; Fairlamb, AH; Fersing, C; Hutter, S; Laget, M; Milne, R; Pedron, J; Piednoel, M; Primas, N; Rathelot, P; Since, M; Sournia-Saquet, A; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S1
Azas, N; Boudot, C; Bourgeade-Delmas, S; Boutet-Robinet, É; Brossas, JY; Castera-Ducros, C; Corvaisier, S; Courtioux, B; Destere, A; Fairlamb, AH; Fersing, C; Hutter, S; Malzert-Fréon, A; Mazier, D; Paoli-Lombardo, R; Paris, L; Pedron, J; Pinault, E; Primas, N; Rathelot, P; Seguy, L; Since, M; Sournia-Saquet, A; Stigliani, JL; Valentin, A; Vanelle, P; Verhaeghe, P; Wyllie, S1

Reviews

1 review(s) available for fexinidazole and miltefosine

ArticleYear
Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases.
    Journal of medicinal chemistry, 2017, 09-28, Volume: 60, Issue:18

    Topics: Animals; Anti-Infective Agents; Bacteria; Bacterial Infections; Communicable Diseases; Humans; Nitroimidazoles; Parasitic Diseases

2017

Other Studies

6 other study(ies) available for fexinidazole and miltefosine

ArticleYear
Targeting the human parasite Leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series.
    Bioorganic & medicinal chemistry, 2013, Nov-15, Volume: 21, Issue:22

    Topics: Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Hep G2 Cells; Humans; Imidazoles; Leishmania donovani; Mice; Pyridines; Structure-Activity Relationship

2013
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series.
    Bioorganic & medicinal chemistry, 2015, May-15, Volume: 23, Issue:10

    Topics: Antiprotozoal Agents; Drug Design; Hep G2 Cells; Humans; Leishmania donovani; Leishmania infantum; Life Cycle Stages; Macrophages; Nitroquinolines; Parasitic Sensitivity Tests; Pentamidine; Phosphorylcholine; Structure-Activity Relationship

2015
Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: Synthesis, electrochemical and SAR study.
    European journal of medicinal chemistry, 2018, Jul-15, Volume: 155

    Topics: Antiprotozoal Agents; Cell Survival; Dose-Response Relationship, Drug; Electrochemical Techniques; Hep G2 Cells; Humans; Kinetoplastida; Leishmania infantum; Molecular Structure; Nitroquinolines; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanosoma brucei brucei

2018
8-Aryl-6-chloro-3-nitro-2-(phenylsulfonylmethyl)imidazo[1,2-a]pyridines as potent antitrypanosomatid molecules bioactivated by type 1 nitroreductases.
    European journal of medicinal chemistry, 2018, Sep-05, Volume: 157

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Hep G2 Cells; Humans; Leishmania donovani; Models, Molecular; Molecular Structure; Nitroreductases; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei

2018
Nongenotoxic 3-Nitroimidazo[1,2-
    ACS medicinal chemistry letters, 2019, Jan-10, Volume: 10, Issue:1

    Topics:

2019
8-Alkynyl-3-nitroimidazopyridines display potent antitrypanosomal activity against both T. b. brucei and cruzi.
    European journal of medicinal chemistry, 2020, Sep-15, Volume: 202

    Topics: Dose-Response Relationship, Drug; Molecular Structure; Nitroimidazoles; Parasitic Sensitivity Tests; Pyridines; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosoma cruzi

2020